BioSpace News Archive

Press Releases

Idorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025

September 9, 2025
·
8 min read
Press Releases

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

September 9, 2025
·
15 min read
Press Releases

ImmunityBio’s ANKTIVA® Reverses Lymphopenia and Extends Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Resistant to Checkpoint Therapy

September 9, 2025
·
12 min read
Press Releases

āshibio Reports Promising Preclinical Data for Two First-in-Class Antibodies Targeting Debilitating Bone Disorders at ASBMR Meeting

September 9, 2025
·
7 min read
Press Releases

Evolus Announces the Appointment of Tatjana Mitchell as Chief Financial Officer

September 9, 2025
·
5 min read
Press Releases

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 9, 2025
·
1 min read
Press Releases

Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study

September 9, 2025
·
7 min read
Press Releases

Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes

September 9, 2025
·
7 min read
Press Releases

NiKang Therapeutics® Completes Dosing of the First Cohort in a Phase 1 Study of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader

September 9, 2025
·
3 min read
Press Releases

Levee Medical® Announces Issuance of Foundational U.S. Patent Covering the Voro® Urologic Scaffold

September 9, 2025
·
2 min read